Quantcast

Latest Insulin therapy Stories

2014-09-22 12:27:57

WORCESTER, Mass. and TORONTO, Sept. 22, 2014 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced that it has entered into a collaboration with University Health Network (UHN) pursuant to which UHN's Centre for Molecular Design and Preformulations (CMDP) will spearhead the Company's buccal insulin refinement project. The goal of the project is to increase the insulin bioavailability of Generex Oral-lyn(TM), the Company's proprietary buccal...

2014-09-18 20:22:43

- Trulicity, a weekly glucagon-like peptide-1 (GLP-1) receptor agonist, is indicated for adults with type 2 diabetes as an adjunct to diet and exercise INDIANAPOLIS, Sept. 18, 2014 /PRNewswire/ -- Trulicity(TM) (dulaglutide), approved today by the U.S. Food and Drug Administration, is the latest Eli Lilly and Company (NYSE: LLY) treatment option for adults with type 2 diabetes. Trulicity is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2...

2014-09-16 08:30:07

ACCU-CHEK Aviva Expert offers people with diabetes a new and easy way to simplify complex calculations to deliver precise insulin dosing advice INDIANAPOLIS, Sept. 16, 2014 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Roche's ACCU-CHEK(®) Aviva Expert system, the first and only blood glucose meter system with a built-in insulin calculator to be approved by the U.S. Food and Drug Administration (FDA), is now available by prescription. The device represents...

2014-09-11 23:06:37

Transparency Market Research published a new report "Global and China Insulin Market: Industry Analysis, Size, Share, Growth, Trends and Forecast (Value and Volume) 2013 - 2019" to its report store. Albany, New York (PRWEB) September 11, 2014 According to a new market report published by Transparency Market Research "Global and China Insulin Market (Rapid-Acting, Short-Acting, Intermediate-Acting, Long-Acting, Premixed, Modern and Human Insulin) - Industry Analysis, Size,...

2014-09-05 16:22:59

LifeScienceIndustryResearch.com adds "Market Research Report on Global and Chinese Insulin (API & Injection) Industry, 2009-2019" to its store. DALLAS, Sept. 5, 2014 /PRNewswire-iReach/ -- This is a professional and in-depth market survey on Global and Chinese Insulin (API & Injection) industry. The report firstly reviews the basic information of Insulin (API & Injection) including its classification, application and manufacturing technology. The report then explores global...

2014-08-26 12:28:35

9 major insurance companies in Canada approved the reimbursement of the Montméd Timesulin under "standard group policies that include coverage for diabetic supplies". MONTREAL, Aug. 26, 2014 When it comes to diabetes supplies, innovations are often accused of having very little clinical relevance. But Timesulin happens to answer a real medical need. Fitting most of insulin disposable pen on the market, Timesulin shows how long it's been since your last injection. One advantage...

2014-08-20 23:09:43

The human insulin market is segmented based on types of insulin, and branded drugs available in the market (http://www.marketsandmarkets.com/Market-Reports/human-insulin-market-229295783.html). (PRWEB) August 20, 2014 The “Human Insulin Market by Product Type [Human Insulin (Short Acting, Intermediate Acting, Premixed), Modern Human Insulin (Rapid Acting, Long Acting, Premixed)], by Brand (Lantus, Apidra, Levemir, NovoRapid, Novomix, Tresiba, Others) - Forecast to 2019” provides a...

2014-08-19 08:30:18

JERUSALEM, August 19, 2014 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the Intellectual Property Department of Spain has granted the Company's patent for its invention, titled "Methods and Compositions for Oral Administrations of Proteins." About Oramed Pharmaceuticals Oramed Pharmaceuticals is a...

2014-08-18 16:23:39

LONDON, Aug. 18, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Insulin Resistance-Pipeline Insights, 2014https://www.reportbuyer.com/product/2278599/-Insulin-Resistance-Pipeline-Insights-2014.htmlSUMMARYDelveInsight's," Insulin Resistance-Pipeline Insights, 2014", report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall...

Researchers Use Fruit Flies To Unlock Mysteries Of human Diabetes
2014-08-11 03:05:27

Stanford University Medical Center For the first time, the tiny fruit fly can be used to study how mutations associated with the development of diabetes affect the production and secretion of the vital hormone insulin. The advance is due to a new technique devised by researchers at the Stanford University School of Medicine that allows scientists to measure insulin levels in the insects with extremely high sensitivity and reproducibility. The experimental model is likely to...


Latest Insulin therapy Reference Libraries

0_0d961f30bdfa64859d9b869b063ddcd2
2010-12-03 18:12:26

Insulin, a hormone, is used to regulate carbohydrate and fat metabolism in the body. Insulin causes cells to take up glucose from the blood and store it as glycogen in the liver and muscle. This hormone stops the body from using fat as an energy source by inhibiting the release of glucagons. Without insulin the body fails to take glucose into the bodies cells and in turns uses fat as an energy source. It also has several other anabolic effects throughout the body. Diabetes mellitus results...

More Articles (1 articles) »
Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related